The abstract is read at the publisher; the summary is JClub's.
Translumbosacral neuromodulation therapy (TNT) at 2400 or 3600 magnetic stimulations weekly for 6 weeks yields higher fecal incontinence response rates than sham in 109 randomized patients.
- Why it matters: Fecal incontinence has no effective disease-modifying options, so a noninvasive, neuropathy-targeting approach needs rigorous sham-controlled evidence for efficacy and safety.
- What they did: In a multicenter double-blind randomized sham-controlled trial, FI patients (≥1 leakage/week) received TNT at 4 lumbosacral sites weekly for 6 weeks, with outcomes tracked via stool diaries and neurophysiology.
- The result: Responders were 65.8% (2400), 81.1% (3600), and 32.4% (sham), with FI Severity Index improving vs sham (P=.02) and nerve conduction latencies and squeeze pressures improving (P<.04, P<.05), with no treatment-related serious adverse events.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.